Delivery Order 36F79722D0178-W912L723F0017
Award Date
6/2/23
Potential Completion Date
6/17/23
Potential Value
$30K
Federal Agency
Tennessee National Guard
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price delivery order for $60,629.10 was awarded by the Minnesota National Guard, a Defense agency, to Glaxosmithkline, LLC to provide hepatitis A/B vaccine. The contract has no set-aside designation and runs through September 30, 2024. Glaxosmithkline, a for-profit pharmaceutical company, has provided a range of vaccines and antiviral medications to U.S. government agencies through federal contracts, including influenza and COVID-19 treatments. This order supports the National...
This is a delivery order award to Glaxosmithkline, LLC for $28,160 to provide vaccines for the Tennessee National Guard. The order was placed against Glaxosmithkline's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract is a firm fixed price arrangement with no set-aside designation. The vaccines will be delivered to the Tennessee National Guard in Research Triangle Park, North Carolina. Glaxosmithkline is a large...
The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...
This is a $770,544.00 firm fixed price purchase order contract awarded by the Department of Defense's (DoD) Medical Supply Chain to Glaxosmithkline, LLC for the provision of hepatitis B virus vaccines. The contract has an ultimate completion date of May 26, 2015 and was awarded on May 13, 2015. There was no set-aside designation used for this award. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antiviral medications, and other products to U.S. government agencies...
This $1,101,022 firm fixed-price purchase order was awarded by the Defense agency Medical Supply Chain to the pharmaceutical company Glaxosmithkline, LLC to provide hepatitis B virus vaccines. The award has an ultimate completion date of February 8, 2017 and was not set aside for any special category of contractor. Glaxosmithkline, which is a foreign-owned for-profit organization, has received numerous federal contracts and grants to supply vaccines, antiviral medications, and other...
This is a $131,896.00 firm fixed price delivery order awarded to Glaxosmithkline, LLC by the Department of Health and Human Services Office of the Assistant Secretary for Administration. The contract provides for the delivery of vaccines, with performance to take place at Glaxosmithkline's facilities in Research Triangle Park, North Carolina. The contract is not designated as a set-aside. Glaxosmithkline is a pharmaceutical company that provides a range of products to federal agencies, including...
This contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to the prime contractor Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines for the government's stock. The $172,923.02 firm fixed price delivery order was issued under Glaxosmithkline's Federal Supply Schedule 61-IB contract for pharmaceuticals and drugs. The award does not have a set-aside designation. Glaxosmithkline is a...
This is a $144,059.82 firm fixed price delivery order awarded by the Department of Health and Human Services to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines and other pharmaceutical products. The contract is issued under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The delivery order supports disease prevention efforts, immunization programs, and healthcare services, with performance in...
This federal contract award to Glaxosmithkline, LLC was issued by the Department of Health and Human Services for the delivery of vaccines. The $78,273.48 firm fixed price Delivery Order was placed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract supports government vaccine stockpiling efforts, with performance occurring at Glaxosmithkline's facilities in North Carolina. The contract has no set-aside designation. Glaxosmithkline is a major pharmaceutical...
This is a $105,351.10 delivery order contract awarded by the Department of Health and Human Services (HHS) to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, for the supply of vaccines. The contract is not set-aside and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The vaccines will be delivered from Glaxosmithkline's facilities in Research Triangle Park, North Carolina. Glaxosmithkline has a range of federal...